Vol. 8, Issue 1, Part A (2026)

Background: Alcohol-associated liver disease (ALD) and liver-related mortality constitute a significant worldwide health burden, resulting from acute or chronic alcohol usage. Chronic alcohol intake impairs the liver's natural defence mechanisms and likely disrupts the intestinal barrier system and mucosal immune cells, resulting in diminished nutritional absorption. Flavonoid intake, characterised by liver-protective, antioxidant, and anti-inflammatory properties, is a crucial dietary element for improving liver function.

Purpose: The present study was conducted to evaluate the efficacy of Myricetin for their hepatoprotective potential.

Methodology: The scientific validation of the present work was conducted using a computational molecular docking analysis of the lead compounds myricetin against the CYP2E1 enzyme.

Result: The results of the current analysis indicate that the myricetin are efficient hepatoprotective agent, demonstrating binding affinities to the target protein CYP2E1 with binding energy of -8.26 kcal/mol.

Conclusion: The results demonstrated that chosen lead compound for further study exhibited substantial inhibitory efficacy against CYP2E1 hence indicating its potential role in alcohol induced liver toxicity.